Fact CheckerSign in

NCT07070128Recruiting

Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer

Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer (STAR-BREAST)

Source: ClinicalTrials.gov · Last updated 29 Jul 2026

Brief summary (registry, in English)

It is a retrospective observational study that will include female patients aged 18 years or older, who were treated between 2017 and 2024, in both public and private institutions, and identified as at high genetic risk by breast specialists and referred to a geneticist. The artificial intelligence-based tool to be used in this study is developed by the startup WeConecta, which will collect data via WhatsApp about the patients' family cancer history with the aim of predicting the genetic risk of developing breast cancer.

Status (registry)
Recruiting
Study type
Observational
Enrollment
800 (estimated)
First submitted
16 Apr 2025
Start date
20 Aug 2025
Primary completion date
11 Aug 2026
Lead sponsor
AstraZeneca
NCT number
NCT07070128

What you commit to

  • Study type: Observational
  • Planned participants: 800
  • From 20 Aug 2025 to the primary completion date, 11 Aug 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • male patients,
  • absence of complete information in the medical records,
  • patients unaware of their biological family history, and
  • patients who do not agree to participate in the study.

Who the study is looking for

  • female patients,
  • aged 18 years or older,
  • identified as high genetic risk by breast surgeons,
  • referred to a geneticist, and
  • who agree to participate in the study.

Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
-
Coordinator of this site? Confirm its status
GolaniaBrazilWithdrawn
-
Coordinator of this site? Confirm its status
Porto AlegreBrazilRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.